サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/31 | 1,036 | 1,092 | 1,036 | 1,083 | +43 | +4.1% | 329,300 |
2022/01/28 | 1,080 | 1,097 | 1,017 | 1,040 | -29 | -2.7% | 312,200 |
2022/01/27 | 1,124 | 1,140 | 1,057 | 1,069 | -27 | -2.5% | 340,600 |
2022/01/26 | 1,052 | 1,115 | 1,052 | 1,096 | +41 | +3.9% | 275,800 |
2022/01/25 | 1,139 | 1,145 | 1,047 | 1,055 | -56 | -5% | 463,300 |
2022/01/24 | 1,095 | 1,120 | 1,075 | 1,111 | -10 | -0.9% | 299,100 |
2022/01/21 | 1,168 | 1,179 | 1,115 | 1,121 | -71 | -6% | 388,600 |
2022/01/20 | 1,193 | 1,223 | 1,167 | 1,192 | -16 | -1.3% | 340,800 |
2022/01/19 | 1,250 | 1,253 | 1,199 | 1,208 | -45 | -3.6% | 366,400 |
2022/01/18 | 1,255 | 1,295 | 1,242 | 1,253 | +3 | +0.2% | 338,800 |
2022/01/17 | 1,300 | 1,314 | 1,241 | 1,250 | -50 | -3.8% | 390,000 |
2022/01/14 | 1,250 | 1,321 | 1,242 | 1,300 | +50 | +4% | 671,900 |
2022/01/13 | 1,250 | 1,273 | 1,239 | 1,250 | -43 | -3.3% | 380,800 |
2022/01/12 | 1,303 | 1,325 | 1,255 | 1,293 | -11 | -0.8% | 855,200 |
2022/01/11 | 1,171 | 1,325 | 1,160 | 1,304 | +125 | +10.6% | 1,564,800 |
2022/01/07 | 1,082 | 1,223 | 1,057 | 1,179 | +119 | +11.2% | 1,072,700 |
2022/01/06 | 1,055 | 1,088 | 1,053 | 1,060 | -16 | -1.5% | 294,400 |
2022/01/05 | 1,050 | 1,098 | 1,028 | 1,076 | +22 | +2.1% | 365,900 |
2022/01/04 | 1,029 | 1,059 | 1,005 | 1,054 | +47 | +4.7% | 544,500 |
2021/12/30 | 1,016 | 1,017 | 996 | 1,007 | -9 | -0.9% | 320,800 |
2021/12/29 | 1,019 | 1,038 | 990 | 1,016 | +13 | +1.3% | 472,600 |
2021/12/28 | 1,050 | 1,061 | 998 | 1,003 | -39 | -3.7% | 786,800 |
2021/12/27 | 1,108 | 1,108 | 1,037 | 1,042 | -83 | -7.4% | 711,500 |
2021/12/24 | 1,131 | 1,153 | 1,120 | 1,125 | -8 | -0.7% | 362,700 |
2021/12/23 | 1,165 | 1,172 | 1,131 | 1,133 | -40 | -3.4% | 385,700 |
2021/12/22 | 1,140 | 1,183 | 1,131 | 1,173 | +15 | +1.3% | 583,100 |
2021/12/21 | 1,214 | 1,223 | 1,138 | 1,158 | -45 | -3.7% | 844,500 |
2021/12/20 | 1,115 | 1,221 | 1,111 | 1,203 | +71 | +6.3% | 1,846,000 |
2021/12/17 | 1,177 | 1,254 | 1,044 | 1,132 | +35 | +3.2% | 6,320,300 |
2021/12/16 | 1,097 | 1,097 | 1,097 | 1,097 | +150 | +15.8% | 92,100 |
2021/12/15 | 940 | 951 | 933 | 947 | -8 | -0.8% | 442,800 |
2021/12/14 | 964 | 978 | 942 | 955 | -21 | -2.2% | 491,400 |
2021/12/13 | 1,020 | 1,030 | 968 | 976 | -49 | -4.8% | 600,700 |
2021/12/10 | 1,050 | 1,054 | 1,025 | 1,025 | -29 | -2.8% | 255,100 |
2021/12/09 | 1,049 | 1,075 | 1,041 | 1,054 | +8 | +0.8% | 365,300 |
2021/12/08 | 1,000 | 1,049 | 999 | 1,046 | +60 | +6.1% | 650,300 |
2021/12/07 | 950 | 991 | 950 | 986 | +35 | +3.7% | 604,600 |
2021/12/06 | 990 | 992 | 940 | 951 | -64 | -6.3% | 807,600 |
2021/12/03 | 987 | 1,015 | 982 | 1,015 | +34 | +3.5% | 418,100 |
2021/12/02 | 1,006 | 1,017 | 980 | 981 | -37 | -3.6% | 508,900 |
2021/12/01 | 1,033 | 1,035 | 997 | 1,018 | -15 | -1.5% | 515,400 |
2021/11/30 | 1,029 | 1,066 | 1,016 | 1,033 | +20 | +2% | 508,500 |
2021/11/29 | 1,051 | 1,073 | 1,011 | 1,013 | -70 | -6.5% | 982,500 |
2021/11/26 | 1,140 | 1,144 | 1,071 | 1,083 | -71 | -6.2% | 759,100 |
2021/11/25 | 1,164 | 1,180 | 1,137 | 1,154 | -4 | -0.3% | 361,900 |
2021/11/24 | 1,208 | 1,208 | 1,157 | 1,158 | -63 | -5.2% | 497,600 |
2021/11/22 | 1,212 | 1,227 | 1,189 | 1,221 | -10 | -0.8% | 280,800 |
2021/11/19 | 1,302 | 1,302 | 1,231 | 1,231 | -73 | -5.6% | 382,500 |
2021/11/18 | 1,291 | 1,318 | 1,261 | 1,304 | +24 | +1.9% | 644,200 |
2021/11/17 | 1,307 | 1,338 | 1,238 | 1,280 | +59 | +4.8% | 1,409,500 |
801~
850
件表示中 / 2464件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 240,900円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 386,700円 | +30.5% | +111.0% | 4.91% | 10.90倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 261,300円 | +13.9% | +6.6% | 2.68% | 6.81倍 | 0.81倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 237,400円 | +21.7% | +999.9% | 0.00% | 9.89倍 | 3.27倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム